Targets › ITGA6
1 program from 1 company in 1 trial: 1 Phase 1; Oncology; next expected readout Dec 2034.
Integrin alpha-6/beta-1 (ITGA6:ITGB1) is a receptor for laminin on platelets (By similarity). Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). (UniProt, P23229)
Open in Phaseline: the race on ITGA6, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Institute of Automation, Chinese Academy of Sciences | RD-Cy7 fluorophore ITGA6-targeting NIR-II fluorescence imaging probe | ITGA6 | Phase 1 | Hepatocellular Carcinoma | Dec 2034 |
Hepatocellular Carcinoma (1)
small molecule (1)
Institute of Automation, Chinese Academy of Sciences (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.